Cite Filings / MLYS / 0000315066-26-000484

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Mineralys Therapeutics, Inc. Filed 2026-02-05 Acc 0000315066-26-000484

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-12 144 Sale of Securities
2026-02-11 4 Chief Medical Officer sold 2,171 shares at $30.21 ($65,586)
2026-02-09 144 Sale of Securities
2026-02-05 SCHEDULE 13G Statement of Beneficial Ownership
2026-01-21 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…